Introduction Epilepsy affects over 50 million individuals worldwide, and nearly one-third continue to experience seizures despite available antiseizure medications (ASMs). This persistent treatment gap has accelerated the development of novel molecules targeting mechanisms beyond traditional sodium channel blockade or GABA modulation. Novel Ion Cha
1 Reached
Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes
Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes
Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes
Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes
OSA in Child
597 Reached3 Comments2 Likes